## Abstract Starting from the chiral compound 1, (R)‐(+)‐2‐methyl‐1,4‐[^14^C]butanediamine 7 was synthesized in a sequence of reactions in which ^14^C‐label was introduce using label potassium cyanide. Compound 7 was reacted with potassium tetraiodoplatinate and silver 1,1‐cyclobutanedicarboxylate
A microscale synthesis of a promising radiolabelled antitumor drug: Cis-1,1-cyclobutanedicarboxylato (2R)-2-methyl-1,4-butanediamine platinum(II), NK121
✍ Scribed by Masato Suwa; Osamu Kogawa; Hiroyoshi Nowatari; Yuko Murase; Yoshio Homma; Yutaka Hashimoto
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- French
- Weight
- 250 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A promising antitumor drug, cis‐1,1‐cyclobutane‐dicarboxylato (2R)‐2‐methyl‐1,4‐butanediamine platinum(II), NK121, was synthesized from radionuclides of platinum such as ^193m^Pt, ^195m^Pt and ^191^Pt which were produced by neutron irradiation of enriched ^192^Pt. The overall yield was 38.6% in a synthesis time of 10 hours. The radioactivities present in 8.39 mg of NK121 were 115.3 μCi as ^193m^Pt, 29.9 μCi as ^197^Pt, 22.0 μCi as ^195m^Pt, and 4.8 μCi as ^191^Pt at the end of synthesis. The specific activity of the NK121 was 13.7 μCi (^193m^Pt)/mg NK121 at the end of synthesis. The radiochemical purity of NK121 was typically 99 %. HPLC analyses confirmed that NK121 was in an adequate chemical purity and suitable for animal experimentation.
📜 SIMILAR VOLUMES
The synthesis of the title compound (3) is described. Treatment of a solution of triethyl [14C]orthoformate in dry chloroform with cis-[4-(2,5-diamino-6-chloro-4-pyrimidinyl) -amino] -2cyclopentenyl]carbinol (1) afforded crude 2. Hydrolysis of crude 2 with 2 N sodium Eydroxide gave 3 in 34% overall